Company Long-Term Loans and Borrowings: Jaguar Animal Health (JAGX)

Public company logo of Jaguar Health Inc (JAGX)

Jaguar Health, Inc. (JAGX) management is focused on developing plant-based therapies for human and animal gastrointestinal health, actively penetrating new market niches. Business growth relies on the commercialization of Mytesi, the advancement of final-stage clinical trials, and the expansion of insurance coverage, with the indicator standing at 0.02. This stock price chart confirms the company's status as an ethical brand that enjoys deep trust from both the medical community and patients.

JAGX Jaguar Health, Inc. Company Long-Term Debts (07/04/2022 - 11/01/2026)

Jaguar Animal Health (JAGX) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price jaguar.health|JAGX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Jaguar Health|JAGX - Total Company Value
- book capitalization information:
Accounting Value per Share Jaguar Health|JAGX - Book Capitalization|Market Capitalization to Book Value Ratio jaguar.health|JAGX - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Jaguar Health, Inc.|JAGX - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Jaguar Health Corp|JAGX - Company Aggregate Debts|Debts to Net Assets Jaguar Health|JAGX - Company Long-Term Liabilities|Amount of Current Liabilities Jaguar Health|Intermediate Liquidity Ratio jaguar.health
- earnings and multiples data:
JAGX - Net Profit
Summary company analytics:JAGX jaguar.health
Brand item of Jaguar Animal Health

Portfolio managers are closely evaluating the operating model of Jaguar Health, Inc. (JAGX). This indicator measures the total volume of debt with a maturity exceeding twelve months. Analyzing the dynamics of the issuer's long-term liabilities allows for an assessment of the credit load on capital. For a company with production split between South America and the US, this metric reflects the cost of maintaining logistical stability. A reduction in debt confirms the financial stability of the business structure.

Competitor analysis for Jaguar Health, Inc.

Company Long-Term Debts phathompharma.com PHAT|TERN - Company Long-Term Debt|Company Long-Term Loans and Borrowings IRWD (Ironwood Pharmaceuticals)|curanexpharma.com (CURX) - Company Long-Term Debt|Company Long-Term Liabilities Immuron|EVOK (Evoke Pharma, Inc.) - Company Long-Term Debts|Company Long-Term Debts Entero|Company Long-Term Liabilities RDHL (RedHill Biopharma)|PALI (palisadebio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts BIOR (Progenity)|Long-Term Indebtedness Morphic Holding Corp